pyrroles has been researched along with indinavir sulfate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Darke, PL; Hirschmann, R; Holloway, MK; Kuo, LC; Pasternak, A; Schleif, WA; Smith, AB; Sprengeler, PA; Yao, W | 1 |
Chapman, KT; Duffy, JL; Emini, EA; Jin, L; Kevin, NJ; Kirk, BA; Kuo, LC; Lin, JH; Olsen, DB; Rutkowski, CA; Schleif, WA; Stahlhut, M; Tata, JR | 1 |
2 other study(ies) available for pyrroles and indinavir sulfate
Article | Year |
---|---|
An orally bioavailable pyrrolinone inhibitor of HIV-1 protease: computational analysis and X-ray crystal structure of the enzyme complex.
Topics: Administration, Oral; Antiviral Agents; Biological Availability; Crystallography, X-Ray; Dipeptides; Drug Design; HIV Protease; HIV Protease Inhibitors; Hydrogen Bonding; Indinavir; Indoles; Models, Molecular; Molecular Weight; Protein Conformation; Pyrroles | 1997 |
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavir.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Design; Drug Resistance, Viral; Drug Therapy, Combination; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Microsomes, Liver; Pyrroles; Structure-Activity Relationship | 2003 |